Basics Ovid Therapeutics Inc. Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders. IPO Date: May 10, 2017 Sector: Healthcare Industry: Biotech Market Cap: $113.78M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.37% Avg Daily Range (30 D): $0.09 | 6.07% Avg Daily Range (90 D): $0.05 | 5.63% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): 3.52M Avg Daily Volume (90 D): 2.2M Trade Size Avg Trade Size (Sh.): 206 Avg Trade Size (Sh.) (30 D): 305 Avg Trade Size (Sh.) (90 D): 351 Institutional Trades Total Inst.Trades: 114 Avg Inst. Trade: $2.12M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $1.05M Avg Inst. Trade Volume: .56M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.45M Avg Closing Trade (30 D): $1.44M Avg Closing Trade (90 D): $1.44M Avg Closing Volume: 821.93K     News Feb 27, 2025 @ 1:00 PM Ovid Therapeutics to Present at the TD Cowen 45th ... Source: N/A Feb 20, 2025 @ 6:00 PM Epilepsy Market Assessment in the 7MM by 2034 ââ‚... Source: Delveinsight Feb 5, 2025 @ 1:00 PM Ovid Therapeutics to Present at the Oppenheimer 35... Source: N/A Jul 1, 2024 @ 12:00 PM Ovid Therapeutics and Graviton Bioscience Announce... Source: Ovid Therapeutics Inc. Jun 30, 2024 @ 1:10 PM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Financials   TTM Q1 2025 Q4 2024 Basic EPS Diluted EPS Revenue $ .55M $ .13M $ .08M Gross Profit $ $ $ Net Income / Loss $ -24.97M $ -10.24M $ -9.25M Operating Income / Loss $ -57.02M $ -12.55M $ -10.72M Cost of Revenue $ $ $ Net Cash Flow $ -9.64M $ -5.17M $ 11.28M PE Ratio